Abstract:The complex symbiotic relationship between inflammation, the gut microbiota, and the central nervous system (CNS) has become a pivotal focus of contemporary biomedical research. Inflammation, as a physiological defense mechanism, plays a dual role as both a protective and pathological factor, and is intricately associated with gut microbiota homeostasis, often termed the "second brain." The gutbrain axis (GBA) exemplifies this multifaceted interaction, where gut health exerts significantly regulatory effects on CNS functions. Antibacterial therapies represent both promising and challenging strategies for modulating inflammation and gut microbiota composition to confer CNS benefits. However, while such therapies may exert positive modulatory effects on the gut microbiota, they also carry the potential to disrupt microbial equilibrium, potentially exacerbating neurological dysfunction. Recent advances have provided critical insights into the therapeutic implications of antibacterial interventions; nevertheless, the application of these therapies in the context of CNS health warrants a judicious and evidence-based approach. As research progresses, deeper investigation into the microbial-neural interface is essential to fully realize the potential of therapies targeting inflammation and the gut microbiota for CNS health. Future efforts should focus on refining antibacterial interventions to modulate the gut microbiota while minimizing disruption to microbial balance, thereby reducing risks and enhancing efficacy in CNS-related conditions. In conclusion, despite challenges, a more comprehensive understanding of the GBA, along with precise modulation through targeted antibacterial therapies, offers significant promise for advancing CNS disorder treatment. Continued research in this area will lead to innovative interventions and improved patient outcomes.

Emerging Insights into Postoperative Neurocognitive Disorders: The Role of Signaling Across the Gut-Brain Axis

Crosstalk Between the Gut Microbiota and the Brain: an Update on Neuroimaging Findings

The Role of Gut Microbiota—Gut—Brain Axis in Perioperative Neurocognitive Dysfunction

Gut microbiota in perioperative neurocognitive disorders: current evidence and future directions

Gut-Brain Axis: Possible Role of Gut Microbiota in Perioperative Neurocognitive Disorders

Gut-brain axis: A matter of health and disease in neuropsychiatric disorders…!

Gut-brain axis: A matter of concern in neuropsychiatric disorders ...!

Exploring the gut microbiome-Postoperative Cognitive Dysfunction connection: Mechanisms, clinical implications, and future directions

The potential mechanism of postoperative cognitive dysfunction in older people

Perioperative neurocognitive dysfunction: thinking from the gut?

Research progress on intestinal microbiota regulating cognitive function through the gut-brain axis

The Role of the Intestinal Flora and Its Derivatives in Neurocognitive Disorders: A Narrative Review from Surgical Perspective

Microbiota-gut-brain axis in perioperative neurocognitive and depressive disorders: Pathogenesis to treatment

Impact of gut-brain interaction in emerging neurological disorders

Neuroinflammation in perioperative neurocognitive disorders: From bench to the bedside

Targeting Gut Microbiota Dysbiosis: Potential Intervention Strategies for Neurological Disorders

Impact of microbiota on central nervous system and neurological diseases: the gut-brain axis

Neuroinflammation as the Underlying Mechanism of Postoperative Cognitive Dysfunction and Therapeutic Strategies

Possible Association Between Postoperative Cognitive Dysfunction and Central Neuroinflammation

Advances in Brain–Gut–Microbiome Interactions: A Comprehensive Update on Signaling Mechanisms, Disorders, and Therapeutic Implications

Targeting inflammation and gut microbiota with antibacterial therapy: Implications for central nervous system health